Filing Flows › Rockwell Medical (RMTI) › Q2 2026
Rockwell Medical (RMTI) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 13, 2026
Rockwell Medical (RMTI) reported revenue of $17.8M for the second quarter 2026 (Q2 2026), +11% from a year earlier and +3% from the quarter before. Operating margin was -6.0%, net loss $1.2M (6.6% of revenue).
Rockwell Medical, Q2 2026: revenue $17.8M (+11% year over year), operating margin -6.0%, net loss $1.2M, operating cash flow $2.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.8M | +3% | +11% |
| Operating profit | −$1.1M | — | — |
| Net earnings | −$1.2M | — | — |
| Operating cash flow | $2.1M | — | +13% |
| Free cash flow | $1.5M | — | -13% |
What changed
Revenue was $17.8M in Q2 2026, up 11% year over year and up 3% from the previous quarter.
Gross margin was 18.2%, up 2.7 points from Q2 2025. Operating costs exceeded revenue by $1.1M, an operating margin of -6.0%. Operating expenses grew 12% against revenue growth of 11%. The fastest-growing cost line was General & admin (+12%). The quarter ended with a net loss of $1.2M, narrower than the previous quarter's $1.6M loss.
Operating cash flow was $2.1M (up 13% year over year). Non-cash charges added back $492K of depreciation and amortization and $403K of share-based compensation. Working capital and other items added $2.4M. Capital expenditures of $617K left free cash flow of $1.5M.
Questions
What was Rockwell Medical's revenue in the second quarter 2026?
Rockwell Medical (RMTI) reported revenue of $17.8M for the second quarter 2026 (Q2 2026), +11% from a year earlier and +3% from the quarter before.
Was Rockwell Medical profitable in the second quarter 2026?
Operating loss was $1.1M (-6.0% of revenue) and net loss $1.2M.
Source: Rockwell Medical 10-Q on SEC EDGAR.